These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 30689734)

  • 21. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of reward and effort mechanisms in apathy.
    Bonnelle V; Veromann KR; Burnett Heyes S; Lo Sterzo E; Manohar S; Husain M
    J Physiol Paris; 2015; 109(1-3):16-26. PubMed ID: 24747776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
    Pieruccini-Faria F; Jones JA; Almeida QJ
    Neuroscience; 2016 Mar; 318():219-29. PubMed ID: 26794593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heightened effort discounting is a common feature of both apathy and fatigue.
    Jurgelis M; Chong WB; Atkins KJ; Cooper PS; Coxon JP; Chong TT
    Sci Rep; 2021 Nov; 11(1):22283. PubMed ID: 34782630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive effort-based decision-making in major depressive disorder.
    Ang YS; Gelda SE; Pizzagalli DA
    Psychol Med; 2023 Jul; 53(9):4228-4235. PubMed ID: 35466895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of serotonin in modulation of decision-making in Parkinson's disease.
    Nobis L; Maio MR; Saleh Y; Manohar S; Kienast A; McGann E; Husain M
    J Psychopharmacol; 2023 Apr; 37(4):420-431. PubMed ID: 36628992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort.
    Hartmann MN; Hager OM; Reimann AV; Chumbley JR; Kirschner M; Seifritz E; Tobler PN; Kaiser S
    Schizophr Bull; 2015 Mar; 41(2):503-12. PubMed ID: 25053653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered nucleus accumbens functional connectivity precedes apathy in Parkinson's disease.
    Morris LA; Harrison SJ; Melzer TR; Dalrymple-Alford JC; Anderson TJ; MacAskill MR; Le Heron CJ
    Brain; 2023 Jul; 146(7):2739-2752. PubMed ID: 37019846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
    van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
    Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymmetric dopamine loss differentially affects effort to maximize gain or minimize loss.
    Porat O; Hassin-Baer S; Cohen OS; Markus A; Tomer R
    Cortex; 2014 Feb; 51():82-91. PubMed ID: 24267688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic influences on risk preferences of Parkinson's disease patients.
    Kobayashi S; Asano K; Matsuda N; Ugawa Y
    Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reward sensitivity and action in Parkinson's disease patients with and without apathy.
    Muhammed K; Ben Yehuda M; Drew D; Manohar S; Husain M
    Brain Commun; 2021; 3(2):fcab022. PubMed ID: 33855297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced motivation of cognitive control in Parkinson's disease.
    Timmer MHM; Aarts E; Esselink RAJ; Cools R
    Eur J Neurosci; 2018 Sep; 48(6):2374-2384. PubMed ID: 30151991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.
    Kojovic M; Mir P; Trender-Gerhard I; Schneider SA; Pareés I; Edwards MJ; Bhatia KP; Jahanshahi M
    J Neurol; 2014 Jun; 261(6):1080-9. PubMed ID: 24687892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effortful goal-directed behavior in schizophrenia: Computational subtypes and associations with cognition.
    Cooper JA; Barch DM; Reddy LF; Horan WP; Green MF; Treadway MT
    J Abnorm Psychol; 2019 Oct; 128(7):710-722. PubMed ID: 31282687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human subthalamic nucleus encodes the subjective value of reward and the cost of effort during decision-making.
    Zénon A; Duclos Y; Carron R; Witjas T; Baunez C; Régis J; Azulay JP; Brown P; Eusebio A
    Brain; 2016 Jun; 139(Pt 6):1830-43. PubMed ID: 27190012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual Differences in Dopamine Are Associated with Reward Discounting in Clinical Groups But Not in Healthy Adults.
    Castrellon JJ; Seaman KL; Crawford JL; Young JS; Smith CT; Dang LC; Hsu M; Cowan RL; Zald DH; Samanez-Larkin GR
    J Neurosci; 2019 Jan; 39(2):321-332. PubMed ID: 30446530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.